DE2324443A1 - Benzoxazol-derivate und verfahren zu ihrer herstellung - Google Patents

Benzoxazol-derivate und verfahren zu ihrer herstellung

Info

Publication number
DE2324443A1
DE2324443A1 DE2324443A DE2324443A DE2324443A1 DE 2324443 A1 DE2324443 A1 DE 2324443A1 DE 2324443 A DE2324443 A DE 2324443A DE 2324443 A DE2324443 A DE 2324443A DE 2324443 A1 DE2324443 A1 DE 2324443A1
Authority
DE
Germany
Prior art keywords
group
hydrogen
benzoxazolyl
alkyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE2324443A
Other languages
German (de)
English (en)
Inventor
David William Dunwell
Delme Evans
Terence Alan Hicks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of DE2324443A1 publication Critical patent/DE2324443A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
DE2324443A 1972-05-18 1973-05-15 Benzoxazol-derivate und verfahren zu ihrer herstellung Ceased DE2324443A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2340972A GB1435721A (en) 1972-05-18 1972-05-18 Benzoxazole derivatives

Publications (1)

Publication Number Publication Date
DE2324443A1 true DE2324443A1 (de) 1973-11-29

Family

ID=10195157

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2324443A Ceased DE2324443A1 (de) 1972-05-18 1973-05-15 Benzoxazol-derivate und verfahren zu ihrer herstellung

Country Status (31)

Country Link
US (1) US3912748A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (6) JPS5912672B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR780000234B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (4) AR230991A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT333752B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE799790A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG21408A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1029019A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (5) CH587834A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS200455B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1016A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD105229A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2324443A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK140340B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES414863A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2184966B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1435721A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK72579A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU167933B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (2) IE37564B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (2) IL42102A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KE (1) KE2975A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8000063A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL170145C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (3) PH9685A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (3) PL89247B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (2) RO66800A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (3) SE386174B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (3) SU574157A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (3) YU130473A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA732791B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2728323A1 (de) * 1976-06-23 1978-01-19 Int Pharmaceutical Patents Co Optisch aktive derivate von benzoxazolylpropionsaeure, verfahren zu ihrer herstellung und arzneimittel
DE2931255A1 (de) * 1978-08-04 1980-02-28 Ravizza Spa Verfahren zur herstellung von benzoxazolylpropionsaeurederivaten
DE3325672A1 (de) * 1982-07-19 1984-01-19 Ravizza S.p.A., Muggio, Milano Verfahren zur herstellung von benzoxazolylpropionsaeure-derivaten

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087437A (en) * 1976-09-07 1978-05-02 Eli Lilly And Company 2-Phenyl-5-benzoxazolylalkanoic acid purification process
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen
CA1125768A (en) * 1978-10-31 1982-06-15 Hoffmann-La Roche Limited Benzoxazole derivatives
GR75153B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1981-03-27 1984-07-13 Lilly Co Eli
DE3413875A1 (de) * 1984-04-12 1985-10-17 Ludwig Heumann & Co GmbH, 8500 Nürnberg Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
IT1177017B (it) * 1984-10-22 1987-08-26 Ravizza Spa Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico
US4873259A (en) * 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
US4822809A (en) * 1987-11-13 1989-04-18 Abbott Laboratories Benzazole lipoxygenase inhibiting compounds
IT1233836B (it) * 1988-01-13 1992-04-21 Euroresearch Srl Sali idrosolubili dell'acido (+)2-(4 fluorofenil)-alfa-metil-5 benzoxazolo acetato.
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
AU2003283597A1 (en) * 2002-11-16 2004-06-15 Oxford Glycosciences (Uk) Ltd Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
JP4790594B2 (ja) * 2003-02-25 2011-10-12 トポターゲット ユーケー リミテッド Ｈｄａｃインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物
ME01868B (me) * 2004-12-15 2010-10-31 Dompe Pha R Ma Spa Res & Mfg Derivati 2-arilpropionske kiseline i farmaceutske smeše, koje ih sadrže
CA2609659C (en) 2005-05-26 2014-01-28 Neuron Systems, Inc. Azanaphthalenes, compositions and methods for treating retinal disease
JP5369854B2 (ja) 2008-04-21 2013-12-18 住友化学株式会社 有害節足動物防除組成物および縮合複素環化合物
WO2011072141A1 (en) 2009-12-11 2011-06-16 Neuron Systems, Inc. Compositions and methods for the treatment of macular degeneration
RU2018145691A (ru) 2013-01-23 2019-04-01 Альдейра Терапьютикс, Инк. Заболевания, связанные с токсичным альдегидом, и их лечение
MX2015009444A (es) 2013-01-25 2016-04-15 Aldeyra Therapeutics Inc Trampas novedosas en el tratamiento de la degeneracion macular.
JPWO2016021706A1 (ja) * 2014-08-08 2017-05-25 カズマパートナーズ株式会社 縮合複素環化合物
US10550085B2 (en) 2015-08-21 2020-02-04 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
AU2017264697A1 (en) 2016-05-09 2018-11-22 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
WO2018170476A1 (en) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
AU2018348174A1 (en) 2017-10-10 2020-04-23 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
US12006298B2 (en) 2018-08-06 2024-06-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CA3113462A1 (en) 2018-09-25 2020-04-02 Aldeyra Therapeutics, Inc. Formulations of reproxalap for the treatment of dry eye disease
JP7706758B2 (ja) 2019-03-26 2025-07-14 アルデイラ セラピューティクス， インコーポレイテッド 眼科用製剤およびその使用
WO2020223717A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3137301A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CA3175856A1 (en) 2020-05-13 2021-11-18 Todd Brady Pharmaceutical formulations and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70860A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) *
BE772395A (fr) * 1970-09-10 1972-03-09 Merck & Co Inc Derives de l'acides phenylacetique et procedes pour leur fabrication
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2828074A1 (de) * 1977-06-28 1979-01-11 Lilly Industries Ltd Form ii der 2-(4-chlorphenyl)- alpha -methyl-5-benzoxazolyl-essigsaeure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL285932A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1961-11-27
CH516339A (de) * 1969-03-03 1971-12-15 Ciba Geigy Ag Verwendung von Azolverbindungen als Antioxydantien
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
GB1491863A (en) * 1973-10-23 1977-11-16 Lilly Industries Ltd 2,5-or 2,6-disubstituted benzoxazoles

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70860A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) *
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
BE772395A (fr) * 1970-09-10 1972-03-09 Merck & Co Inc Derives de l'acides phenylacetique et procedes pour leur fabrication
DE2828074A1 (de) * 1977-06-28 1979-01-11 Lilly Industries Ltd Form ii der 2-(4-chlorphenyl)- alpha -methyl-5-benzoxazolyl-essigsaeure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Angewndte Chemie Bd. 84, 1972, S.512-526 *
Arzneimittelforschung Bd. 23, 1973, S.1690-1695, Bd. 22, 1972, 2105-2110, Bd. 31, 1981, S. 730 *
Journal Heterocyclic Chemistry, Bd. 9, 1972, S. 681-682 *
Journal of Pharm. Sciences Vol. 73, 1984, S.579 *
Journal of Rheumatology and Inflammation Vol. 5, 1982, S.274-275 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2728323A1 (de) * 1976-06-23 1978-01-19 Int Pharmaceutical Patents Co Optisch aktive derivate von benzoxazolylpropionsaeure, verfahren zu ihrer herstellung und arzneimittel
DE2931255A1 (de) * 1978-08-04 1980-02-28 Ravizza Spa Verfahren zur herstellung von benzoxazolylpropionsaeurederivaten
DE3325672A1 (de) * 1982-07-19 1984-01-19 Ravizza S.p.A., Muggio, Milano Verfahren zur herstellung von benzoxazolylpropionsaeure-derivaten

Also Published As

Publication number Publication date
YU117079A (en) 1981-08-31
ATA432573A (de) 1976-04-15
HU167933B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-01-28
SE386174B (sv) 1976-08-02
SU574157A3 (ru) 1977-09-25
AR205021A1 (es) 1976-03-31
FR2184966B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-01-12
AR212010A1 (es) 1978-04-28
PL89247B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-11-30
PH9685A (en) 1976-02-10
NL7307018A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-11-20
AR230991A1 (es) 1984-08-31
DD105229A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-04-12
SU582762A3 (ru) 1977-11-30
AR207857A1 (es) 1976-11-08
SE7710602L (sv) 1977-09-21
AT333752B (de) 1976-12-10
JPS56167645A (en) 1981-12-23
CS200455B2 (en) 1980-09-15
SE434399B (sv) 1984-07-23
PL92565B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-04-30
NL170145C (nl) 1982-10-01
MY8000063A (en) 1980-12-31
ES414863A1 (es) 1976-02-01
KR780000234B1 (en) 1978-07-01
JPS56167675A (en) 1981-12-23
PL94208B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-07-30
IE37563B1 (en) 1977-08-17
SU580837A3 (ru) 1977-11-15
IL42102A0 (en) 1973-06-29
CH592071A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-10-14
PH10704A (en) 1977-08-24
IL42102A (en) 1977-07-31
JPS4954363A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-05-27
HK72579A (en) 1979-10-19
IE37564B1 (en) 1977-08-17
DK140340C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-12-31
PH11718A (en) 1978-05-30
GB1435721A (en) 1976-05-12
YU36298B (en) 1982-06-18
ZA732791B (en) 1974-12-24
CA1029019A (en) 1978-04-04
CH587834A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-05-13
JPS56167673A (en) 1981-12-23
RO66800A (ro) 1982-03-24
IE37564L (en) 1973-11-18
CH595361A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-02-15
CH595362A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-02-15
RO66278A (ro) 1981-06-26
JPS56167674A (en) 1981-12-23
SE435838B (sv) 1984-10-22
BE799790A (fr) 1973-11-19
JPS5912672B2 (ja) 1984-03-24
JPS59161346A (ja) 1984-09-12
YU130473A (en) 1981-08-31
BG21408A3 (bg) 1976-05-20
IL48711A0 (en) 1976-02-29
AU5590773A (en) 1974-11-21
KE2975A (en) 1979-07-20
NL170145B (nl) 1982-05-03
IE37563L (en) 1973-11-18
US3912748A (en) 1975-10-14
JPS5929185B2 (ja) 1984-07-18
JPS6021976B2 (ja) 1985-05-30
CH594643A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-01-13
FR2284592B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-01-05
FR2184966A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-12-28
FR2284592A1 (fr) 1976-04-09
YU117179A (en) 1981-08-31
SE7509387L (sv) 1975-08-22
DK140340B (da) 1979-08-06
CY1016A (en) 1979-11-23

Similar Documents

Publication Publication Date Title
DE2324443A1 (de) Benzoxazol-derivate und verfahren zu ihrer herstellung
DE3486009T2 (de) 5-pyridyl-1,3-thiazol-derivate, ihre herstellung und anwendung.
US3679698A (en) 2-nitroimidazoles
DE2756113A1 (de) Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DD215546A5 (de) Verfahren zur herstellung bicyclischer thromboxansynthetase-inhibitoren
DE3736664A1 (de) Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung
DE3027075C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS6242977A (ja) ジ−ｔ−ブチルフエノ−ル化合物
DE2450053A1 (de) 1,2-benzisoxazolderivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen
US3962452A (en) Benzoxazole derivatives as therapeutics
US6673816B1 (en) Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
EP0220573B1 (de) Heterocyclische Verbindungen
DE69521687T2 (de) 4-indol-1-yl-buttersäure derivate, deren herstellung und deren verwendung als inhibitoren für alpha1-adrenerge rezeptoren und testosteron 5alpha-reduktasen
DE2730832A1 (de) Thieno-(2,3-c)- und -(3,2-c)pyridine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3037313A1 (de) Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
USRE29608E (en) Benzoxazole derivatives
DE3883164T2 (de) Rhodanin-Derivate, Verfahren zu ihrer Herstellung, ihre Anwendung und pharmazeutische Zusammensetzungen, die sie enthalten.
US4021440A (en) Cyanomethyl substituted benzoxazoles
US5326769A (en) (S)-1-[(10-chloro-6,7-dihydro-4-oxo-3-phenyl-4H-benzo[a]quino-lizin-1-yl)carbonyl]-3-ethoxypyrrolidine
DE2450042A1 (de) Neue benzoxazolderivate und verfahren zu ihrer herstellung
US3917600A (en) 2-(Benzofuran)-acetamidines
US3655661A (en) Benzothiadiazole compounds
US3962441A (en) Benzoxazole derivatives in treating inflammation, pain and fever
DE2500490C3 (de) Nitrofuranhydrazonderivate, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Zubereitung
AT332870B (de) Verfahren zur herstellung neuer benzoxazol-derivate

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: TUERK, D., DIPL.-CHEM. DR.RER.NAT. GILLE, C., DIPL

8131 Rejection